









Markets
/
Stocks
/
nasdaq-lfmd
/

LifeMD Inc

LFMD



View Detailed Chart

3.229USD

-0.001-0.03%

Market hours （ET）Quotes delayed by 15 min

150.42MMarket Cap

LossP/E TTM



LifeMD Inc

3.229

-0.001-0.03%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Intraday

30m

Today

-0.03%

5 Days

-5.03%

1 Month

-16.13%

6 Months

-78.12%

Year to Date

-34.77%

1 Year

-35.93%

View Detailed Chart

TradingKey Stock Score of LifeMD Inc

Currency: USD Updated: 2025-12-19

Key Insights

LifeMD Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 78/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 9.25.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

LifeMD Inc's Score

Industry at a Glance

Industry Ranking

78 / 208

Overall Ranking

190 / 4582

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Analyst Rating

Based on 8 analysts

Buy

Current Rating

9.250

Target Price

+154.12%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

LifeMD Inc Highlights

StrengthsRisks

LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 78.48% year-on-year.

Fairly Valued

The company’s latest PE is -12.83, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 24.14M shares, increasing 10.27% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 3.48K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 1.53.